GT Biopharma is trading at $6.80, up 10.01% after August CPI matched expectations and supported broader risk-on sentiment.

  • Major indexes are higher: S&P 500 up 1.04%, Nasdaq up 0.98%, and Dow up 1.25%.
  • GT Biopharma is hosting a TriKE platform webinar at 2:00 p.m. Eastern Time on September 11, covering clinical progress and upcoming milestones. The release does not directly attribute the stock move to the webinar.